ValiRx (LON:VAL) Shares Cross Above 50-Day Moving Average of $12.23

ValiRx plc (LON:VALGet Rating)’s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 12.23 ($0.15) and traded as high as GBX 18.85 ($0.23). ValiRx shares last traded at GBX 17.25 ($0.21), with a volume of 1,989,192 shares trading hands.

ValiRx Stock Performance

The firm has a market capitalization of ¬£15.56 million and a PE ratio of -7.50. The company has a debt-to-equity ratio of 1.72, a quick ratio of 11.13 and a current ratio of 11.73. The company’s fifty day moving average price is GBX 12.23 and its two-hundred day moving average price is GBX 20.22.

ValiRx Company Profile

(Get Rating)

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer.

Read More

Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.